Use of linked registry claims data for long term surveillance of devices after endovascular abdominal aortic aneurysm repair: observational surveillance study.

ABSTRACT:

Objective

To evaluate long term outcomes (reintervention and late rupture of abdominal aortic aneurysm) of aortic endografts in real world practice using linked registry claims data.

Design

Observational surveillance study.

Setting

282 centers in the Vascular Quality Initiative Registry linked to United States Medicare claims (2003-18).

Participants

20 489 patients treated with four device types used for endovascular abdominal aortic aneurysm repair (EVAR): 40.6% (n=8310) received the Excluder (Gore), 32.2% (n=6606) the Endurant (Medtronic), 16.0% (n=3281) the Zenith (Cook Medical), and 11.2% (n=2292) the AFX (Endologix). Given modifications to AFX in late 2014, patients who received the AFX device were categorized into two groups: the early AFX group (n=942) a

SUBMITTER: Goodney P 

PROVIDER: S-EPMC9593227 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature